DS
GSK icon

DRW Securities’s GSK GSK Stock Holding History

DRW Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-112,960
Closed -$5.01M – 302
2017
Q4 		$5.01M Buy
+112,960
New +$5.22M 0.53% 25
2017
Q3 		– Sell
-34,000
Closed -$1.83M – 72
2017
Q2 		$1.83M Buy
+34,000
New +$1.81M 0.32% 21

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

DRW Securities's GSK Position: Q2 2026 in Review

DRW Securities reduced its GSK (GSK) stake by 46% in Q2 2026, selling an estimated $5.19M and leaving 114,130 shares worth $5.98M. The position accounts for 0.15% of the portfolio, ranked #103.

DRW Securities first reported a position in GSK in Q4 2014 and has held it in 12 quarters since. The position peaked at $11.7M in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • DRW Securities held 114,130 shares of GSK worth $5.98M as of Q2 2026.
  • DRW Securities sold 98,157 GSK shares in Q2 2026, an estimated $5.19M.
  • GSK made up 0.15% of DRW Securities's portfolio in Q2 2026, its #103 holding.
  • DRW Securities first reported a position in GSK in Q4 2014 and has held it in 12 quarters since.
  • DRW Securities's GSK position peaked at $11.7M in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.